Financial reports
N-CSR/A
Certified annual shareholder report (management investment company) (amended)
19 Mar 24
N-CEN
Annual report (registered investment company)
15 Mar 24
N-CSR
Certified annual shareholder report (management investment company)
15 Mar 24
NT-NCSR/A
Notice of inability to timely file Form N-CSR (amended)
8 Mar 24
NT-NCSR/A
Notice of inability to timely file Form N-CSR (amended)
29 Feb 24
NT-NCSR
Notice of inability to timely file Form N-CSR
29 Feb 24
N-CSRS
Certified semi-annual shareholder report (management investment company)
28 Aug 23
N-CEN
Annual report (registered investment company)
16 Mar 23
N-CSR
Certified annual shareholder report (management investment company)
1 Mar 23
N-CSR/A
Certified annual shareholder report (management investment company) (amended)
14 Nov 22
Current reports
8-K
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
25 Mar 24
8-K
Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer
2 Jan 24
8-K
Other Events
27 Nov 23
8-K
Other Events
27 Oct 23
8-K
Submission of Matters to a Vote of Security Holders
13 Jul 23
8-K
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
25 May 23
8-K
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
21 Nov 22
8-K
Submission of Matters to a Vote of Security Holders
29 Jun 22
8-K
Daxor Corporation Commences Trading on The NASDAQ Capital Market
2 Feb 22
8-K
Departure of Directors or Certain Officers
24 Jan 22
Registration and prospectus
25
Voluntary exchange delisting
1 Feb 22
8-A12B
Registration of securities on exchange
1 Feb 22
S-8
Registration of securities for employees
16 Sep 20
POS EX
Additional exhibits for listing
31 Oct 18
RW
Registration withdrawal request
10 May 13
S-8
Registration of securities for employees
6 Jul 04
S-3
Shelf registration
18 Mar 98
Proxies
N-PX
Annual report of proxy voting record
15 Aug 23
DEF 14A
Definitive proxy
21 Jun 23
N-PX
Annual report of proxy voting record
29 Aug 22
DEF 14A
Definitive proxy
31 May 22
N-PX
Annual report of proxy voting record
31 Aug 21
DEF 14A
Definitive proxy
2 Jun 21
N-PX
Annual report of proxy voting record
1 Sep 20
DEF 14A
Definitive proxy
4 Jun 20
N-PX
Annual report of proxy voting record
30 Aug 19
DEFR14A
Revised proxy
3 Jun 19
Other
CORRESP
Correspondence with SEC
14 Feb 24
CERT
Certification of approval for exchange listing
1 Feb 22
EFFECT
Notice of effectiveness
19 Jul 21
CORRESP
Correspondence with SEC
13 Jul 21
EFFECT
Notice of effectiveness
15 Jul 20
CORRESP
Correspondence with SEC
13 Jul 20
EFFECT
Notice of effectiveness
23 May 19
CORRESP
Correspondence with SEC
20 May 19
CORRESP
Correspondence with SEC
17 May 19
CORRESP
Correspondence with SEC
10 May 19
Ownership
4
Robert J Michel
27 Mar 24
4
Edward Feuer
6 Mar 24
4
Robert J Michel
6 Dec 23
4
Robert J Michel
1 Dec 23
4
Michael Richard Feldschuh
1 Dec 23
4
Robert J Michel
27 Nov 23
NPORT-P
None (Sep 2023 report)
24 Nov 23
4
Michael Richard Feldschuh
24 Nov 23
4
Michael Richard Feldschuh
13 Nov 23
4
Robert J Michel
2 Nov 23